Effect of Fava Bean Protein on Muscle Recovery
The Effect of Vicia Faba Hydrolysate Supplementation on Muscle Strength Recovery
This study is testing if a protein from fava beans can help people recover faster and feel less sore after tough workouts.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 76 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | All |
| Sponsor | PepsiCo Global R&D Industry-sponsored |
| Locations | 1 site (Bradenton, Florida) |
| Trial ID | NCT06837298 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of Vicia faba protein concentrate, known as PeptiStrong®, on reducing delayed onset muscle soreness (DOMS) following strenuous exercise. Participants will receive either the supplement or a placebo for 14 days, with a subgroup switching from placebo to the supplement for the final 3 days. The aim is to assess whether this supplementation can enhance muscle strength recovery and reduce soreness after exercise. The study builds on previous findings that suggested benefits of PeptiStrong® in muscle recovery.
Who should consider this trial
Good fit: Ideal candidates are healthy males and females aged 18 to 45 who are moderately active and willing to adhere to study protocols.
Not a fit: Patients who are not physically active or have a BMI outside the range of 18.5 to 29.9 kg/m2 may not benefit from this study.
Why it matters
Potential benefit: If successful, this could provide a nutritional strategy to enhance muscle recovery and reduce soreness for active individuals.
How similar studies have performed: Previous studies have shown promising results with similar protein supplementation approaches, indicating potential for success in this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males and females 18 - 45 years of age. * Willing to fast overnight on the 4 testing occasions. * Participants agree to abstain from taking additional supplements throughout the testing period, with particular emphasis placed upon protein-based products (e.g., whey or casein based protein powders; animal derived protein hydrolysates; natural supplements constituted of vegetative protein hydrolysates from rice, fava bean, pea, carrot, spirulina, broccoli, potatoes; marine derived secondary metabolite products or protein hydrolysates including Omega-3 capsules or DHA). * Moderately active (exercise 3-5 days per week) * Fluent in reading, writing, and speaking English * Participants agree to maintain their normal diet and perform only light to moderate exercise for the duration of the study. * BMI between 18.5 and 29.9 kg/m2 * Participants agree to refrain from consuming alcohol in the 48 hours leading up to a test day. * Willingness to complete questionnaires, records and diaries associated with the study and to complete all lab visits. * Refrain from any exercise from 48 hours prior to each test or blood draw. * Healthy as determined by General Health Questionnaire. * Non-smoker Exclusion Criteria: * Individuals that are glucose-6-phosphate-dehydrogenase deficient. The test product in this study contains fava bean extract which may produce favism in genetically susceptible individuals. * Alcohol or drug abuse in the past year.3. Testosterone or estrogen supplementation (not including women on oral contraceptives) * Pregnant or nursing or planning to become pregnant. * Participation in any other clinical trial in the past 30 days. Participation in any PepsiCo trial in the past 6 months * Volunteers with unstable medical conditions. * Any complaints that could interfere with the ability to exercise. * Individuals who are cognitively impaired or unable to give informed consent. * Any co-morbidities interacting with mobility or muscle metabolism of the lower limbs (e.g. arthritis, spasticity / rigidity, all neurological disorders, paralysis). * Creatine supplements, corticosteroids, NSAIDS, amino acids, injectible peptides, collagen, and nicotinamide (Vit B3/niacin). * Presence or history of neurological disorders or significant psychiatric illness. * Any condition the study investigator believes would interfere with eligibility following the study protocol, effect the study results, or put the subject at undue risk. * Participation in resistance or aerobic exercise within 48 hours of the test days. * Participation of \>3 high-intensity exercise sessions per week. * Undertake recovery methods such as sea swims, foam rolling, cryotherapy or excessive stretching during days 14-17. * Have been in contact with a suspected or confirmed case of COVID-19 in previous 14 days. * Are Hepatitis A- or B-positive or have had a sexual partner infected with hepatitis or HIV and not taking medication. * Are not employed by, or have a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If you are unsure if a company would be considered a competitor to Gatorade, let the study investigator know the name of the other company and the nature of your relationship to that company before ou sign the informed consent
Where this trial is running
Bradenton, Florida
- Gatorade Sports Science Institute at IMG Academy — Bradenton, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Kris Osterberg, PhD, RD — PepsiCo R&D Life Sciences, Sports Science
- Study coordinator: Kris Osterberg, PhD, RD
- Email: kris.osterberg@pepsico.com
- Phone: 847.707.3118
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.